Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammed Eslam

Showing results (11-20 of 224) with videos related to

Pageof 23
Sort By:
Journal of Hepatology|January 16, 2021
MAFLD: A game changer redefining fatty liver disease for adults and childrenMohammed Eslam, Jacob George
Journal of Hepatology|January 16, 2021
MAFLD: A holistic view to redefining fatty liver diseaseMohammed Eslam, Jacob George
Journal of Hepatology|August 18, 2020
Reply to: Correspondence on "A new definition for metabolic associated fatty liver disease: an international expert consensus statement": MAFLD: Moving from a concept to practiceMohammed Eslam, Jacob George
Hepatobiliary Surgery and Nutrition|November 11, 2021
Metabolic associated fatty liver disease (MAFLD): a milestone in the history of fatty liver diseaseJawaher Alharthi, Mohammed Eslam
Trends in Pharmacological Sciences|June 5, 2019
Genetic Insights for Drug Development in NAFLDMohammed Eslam, Jacob George
Liver International : Official Journal of the International Association for the Study of the Liver|May 27, 2024
Bringing evidence to the MAFLD-MASLD debateZiyan Pan, Mohammed Eslam
Journal of Hepatology|February 15, 2021
MAFLD: Now is the time to capitalize on the momentumMohammed Eslam, Jacob George
Hepatology International|October 17, 2022
Metabolically healthy obese and MAFLD: does weight status alone matter?Ziyan Pan, Mohammed Eslam
Egastroenterology|February 13, 2025
Two years on, a perspective on MAFLDMohammed Eslam, Jacob George
Hepatology International|March 20, 2015
Is hepatitis C subtyping still relevant in the era of direct-acting antiviral therapy?Mohammed Eslam, Jacob George
Pageof 23

Showing results (11-20 of 224) with videos related to

Sort By:
Pageof 23
Journal of Hepatology|January 16, 2021
MAFLD: A game changer redefining fatty liver disease for adults and childrenMohammed Eslam, Jacob George
Journal of Hepatology|January 16, 2021
MAFLD: A holistic view to redefining fatty liver diseaseMohammed Eslam, Jacob George
Journal of Hepatology|August 18, 2020
Reply to: Correspondence on "A new definition for metabolic associated fatty liver disease: an international expert consensus statement": MAFLD: Moving from a concept to practiceMohammed Eslam, Jacob George
Hepatobiliary Surgery and Nutrition|November 11, 2021
Metabolic associated fatty liver disease (MAFLD): a milestone in the history of fatty liver diseaseJawaher Alharthi, Mohammed Eslam
Trends in Pharmacological Sciences|June 5, 2019
Genetic Insights for Drug Development in NAFLDMohammed Eslam, Jacob George
Liver International : Official Journal of the International Association for the Study of the Liver|May 27, 2024
Bringing evidence to the MAFLD-MASLD debateZiyan Pan, Mohammed Eslam
Journal of Hepatology|February 15, 2021
MAFLD: Now is the time to capitalize on the momentumMohammed Eslam, Jacob George
Hepatology International|October 17, 2022
Metabolically healthy obese and MAFLD: does weight status alone matter?Ziyan Pan, Mohammed Eslam
Egastroenterology|February 13, 2025
Two years on, a perspective on MAFLDMohammed Eslam, Jacob George
Hepatology International|March 20, 2015
Is hepatitis C subtyping still relevant in the era of direct-acting antiviral therapy?Mohammed Eslam, Jacob George
Pageof 23